http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9311238-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bbfb7e660655692c85ee1eb18599bec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac9393f4d241d76df48940724e49fa49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
filingDate 1992-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_370916cb972cb6177b2c73e7efd5ec3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37985ac4d6855ecf7d375832c3b6d84b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e766ff0f0cc3d15884a2af9dbf781558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e29657c879f14e2113985a3582c013f4
publicationDate 1993-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9311238-A1
titleOfInvention Humanized b-b10, an anti-il2 receptor antibody
abstract A humanized antibody is provided, which is obtained by transplantation of the complementarity determining region of a mouse monoclonal antibody B-B10 specific to a human IL-2 receptor into a human antibody. The antibody has a very low antigenicity, and therefore, it is useful for treatment of carcinoma expressing IL-2 receptor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0172845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7524818-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6811779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700909-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021228218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5874542-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2793691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5861499-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143025-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6448077-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5571787-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840301-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0071159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018167104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6013256-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5955311-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0030679-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6365157-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6559124-B1
priorityDate 1991-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9109967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9007861-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9944261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127922471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128982099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22994805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54226752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230894408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129763036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128917894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226530546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128094727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID547739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77949

Total number of triples: 85.